| Clinical pharmacokinetics of tacrolimus R Venkataramanan, A Swaminathan, T Prasad, A Jain, S Zuckerman, ... Clinical pharmacokinetics 29, 404-430, 1995 | 972 | 1995 |
| Nuclear factor kappa B: important transcription factor and therapeutic target JI Lee, GJ Burckart The Journal of clinical pharmacology 38 (11), 981-993, 1998 | 613 | 1998 |
| Clinical pharmacokinetics of cyclosporin RJ Ptachcinski, R Venkataramanan, GJ Burckart Clinical pharmacokinetics 11, 107-132, 1986 | 536 | 1986 |
| New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process SM Huang, JM Strong, L Zhang, KS Reynolds, S Nallani, R Temple, ... The Journal of clinical pharmacology 48 (6), 662-670, 2008 | 416 | 2008 |
| Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms HX Zheng, S Webber, A Zeevi, E Schuetz, J Zhang, P Bowman, G Boyle, ... American Journal of Transplantation 3 (4), 477-483, 2003 | 346 | 2003 |
| Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use FW Frueh, S Amur, P Mummaneni, RS Epstein, RE Aubert, TM DeLuca, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (8 …, 2008 | 338 | 2008 |
| Extrapolation of adult data and other data in pediatric drug-development programs J Dunne, WJ Rodriguez, MD Murphy, BN Beasley, GJ Burckart, JD Filie, ... Pediatrics 128 (5), e1242-e1249, 2011 | 317 | 2011 |
| A randomized trial of inhaled cyclosporine in lung-transplant recipients AT Iacono, BA Johnson, WF Grgurich, JG Youssef, TE Corcoran, ... New England Journal of Medicine 354 (2), 141-150, 2006 | 260 | 2006 |
| Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism HX Zheng, A Zeevi, E Schuetz, J Lamba, K McCurry, BP Griffith, S Webber, ... The Journal of Clinical Pharmacology 44 (2), 135-140, 2004 | 196 | 2004 |
| Tacrolimus: a new immunosuppressive agent PA Kelly, GJ Burckart, R Venkataramanan American journal of health-system pharmacy 52 (14), 1521-1535, 1995 | 194 | 1995 |
| HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction AL Girnita, R Duquesnoy, SA Yousem, AT Iacono, TE Corcoran, ... American journal of transplantation 5 (1), 131-138, 2005 | 192 | 2005 |
| Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials R Leong, MLT Vieira, P Zhao, Y Mulugeta, CS Lee, SM Huang, ... Clinical Pharmacology & Therapeutics 91 (5), 926-931, 2012 | 187 | 2012 |
| A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. SR Duncan, WF Grgurich, AT Iacono, GJ Burckart, SA Yousem, IL Paradis, ... American journal of respiratory and critical care medicine 150 (1), 146-152, 1994 | 186 | 1994 |
| CYCLOSPORINE A INHIBITS THE EXPRESSION OF COSTIMULATORY MOLECULES ON IN VITRO-GENERATED DENDRITIC CELLS: Association with Reduced Nuclear Translocation of Nuclear Factor Kappa B: 1 JI Lee, RW Ganster, DA Geller, GJ Burckart, AW Thomson, L Lu Transplantation 68 (9), 1255-1263, 1999 | 183 | 1999 |
| Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure JA Carcillo, L Doughty, D Kofos, RF Frye, SS Kaplan, H Sasser, ... Intensive care medicine 29, 980-984, 2003 | 181 | 2003 |
| Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome HR Wong, JA Carcillo, G Burckart, N Shah, JE Janosky Critical care medicine 23 (5), 835-842, 1995 | 170 | 1995 |
| Aerosolized cyclosporine in lung recipients with refractory chronic rejection. AT Iacono, RJ Keenan, SR Duncan, GC Smaldone, JH Dauber, IL Paradis, ... American journal of respiratory and critical care medicine 153 (4), 1451-1455, 1996 | 167 | 1996 |
| HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection AL Girnita, KR McCurry, AT Iacono, R Duquesnoy, TE Corcoran, M Awad, ... The Journal of heart and lung transplantation 23 (10), 1135-1141, 2004 | 160 | 2004 |
| P‐glycoprotein and drug therapy in organ transplantation A Lo, GJ Burckart The Journal of Clinical Pharmacology 39 (10), 995-1005, 1999 | 157 | 1999 |
| Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications Y Zhang, L Zhang, S Abraham, S Apparaju, TC Wu, JM Strong, S Xiao, ... Clinical Pharmacology & Therapeutics 85 (3), 305-311, 2009 | 155 | 2009 |
